Physician profile
James West
NPI 1679009302
$5,342.69
in general payments reported to CMS, 2019-2025
18 companies · $2,260 in 2025
The $2,260 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2022: $260 · 2023: $1,694 · 2024: $944 · 2025: $2,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,156 · Travel and Lodging: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.40 |
| Travel and Lodging | $1,740.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,409.76 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $1,003.16 | 2022-2025 | Corevalve Evolut R, Octopus |
| Edwards Lifesciences Corporation | $856.09 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal, Mitris Resilia Mitral Valve |
| Bolton Medical INC | $287.24 | 2023-2024 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| La Jolla Pharmaceutical Company | $146.73 | 2025 | Giapreza |
| Baxter Healthcare | $113.78 | 2021-2024 | Preveleak |
| Penumbra, INC. | $95.68 | 2021 | |
| Ethicon US, LLC | $66.60 | 2024-2025 | Surgicel Nu-Knit, Prolene, Stratafix |
| Abiomed | $64.88 | 2024-2025 | Impella |
| Kci USA, INC. | $63.26 | 2022-2023 | Activ.A.C. Ion Progress |
| Depuy Synthes Sales INC. | $56.66 | 2025 | Matrixrib |
| Reapplix INC. | $54.85 | 2025 | 3c Patch Kit - Box |
| Intuitive Surgical, INC. | $28.40 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.81 | 2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.93 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $18.52 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $18.26 | 2024 | Verquvo |
| Paladin Technology Solutions | $14.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.